Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-05-09
1999-01-26
Ambrose, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514429, 514438, 514471, 514562, 514564, 548577, 549 77, 549496, 562432, 562437, 562441, 562443, 562444, 562449, A61K 31195, A61K 3134, A61K 3138, A61K 3140, C07C22936, C07C32128, C07D295155, C07D30754, C07D33324
Patent
active
058639470
ABSTRACT:
A pharmaceutical compound of the formula: ##STR1## in which R.sup.1 is hydrogen, hydroxy or C.sub.1-6 alkoxy, R.sup.2 is hydrogen, carboxy, tetrazolyl, --SO.sub.2 H, --SO.sub.3 H, --OSO.sub.3 H, --CONHOH, or --P(OH)OR', --PO(OH)OR', --OP(OH)OR' or --OPO(OH)OR' where R' is hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl or aryl C.sub.1-6 alkyl,
REFERENCES:
patent: 5238958 (1993-08-01), Johnson et al.
patent: 5610183 (1997-03-01), Owens et al.
"Structure-activity relationships of new agonists and antagonists of different motabotropic glutamate receptor subtypes", British Journal of Pharmacology (1996), vol. 117, pp. 1493-1503.
Chemical Abstarcts 110:6394 (1988).
Chemical Abstracts 107:176434 (1987).
Cas Registry No. 116435-35-9.
Harris, C.M. et al. Tetrahedron Letters,(8), 705-708 (1978).
Harris, C.M. et al. Journal of the American Chemical Society, 101(2), 437-445 (1979).
Baker Stephen Richard
Clark Barry Peter
Goldsworthy John
Harris John Richard
Ambrose Michael G.
Boone David E.
Eli Lilly and Company Limited
Hay Martin A.
LandOfFree
Phenylglycine derivatives useful for treating disorders of the c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylglycine derivatives useful for treating disorders of the c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylglycine derivatives useful for treating disorders of the c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1450800